The annual Beau’s 5K for Ovarian Cancer run returned for another edition on Saturday, June 21 in Vankleek Hill. According to ...

According to a new comprehensive report from The Insight Partners, the global ovarian cancer drugs market is observing ...

New findings reveal mirvetuximab soravtansine significantly improves outcomes in patients with recurrent platinum-sensitive ...

For instance, survivors with cancers related to obesity often face higher risks for cancer recurrence and death—not just from ...

The Food and Drug Administration (FDA) has granted accelerated approval to Avmapki ™ (avutometinib) plus Fakzynja ™ (defactinib) for the treatment of adult patients with KRAS- ...

A team of Cyprus-led scientists has made a breakthrough in understanding breast and ovarian cancer with a milestone study that distinguishes “innocent” and “dangerous” genetic errors, the Cyprus ...

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI ...

ABBV's growing oncology portfolio, now spanning five therapies, is helping offset Imbruvica's sales decline and boost ...

Scientists have developed a test which successfully predicts whether cancer will resist common forms of chemotherapy ...

Once the biomarkers were developed, the CNIO team tested them in an innovative way: with a simulated trial, that is, with ...